• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用快球记忆评估对轻度认知障碍中的识别记忆进行被动和客观测量。

A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment.

作者信息

Stothart George, Alderman Sophie, Hermann Oliver, Creavin Sam, Coulthard Elizabeth J

机构信息

Department of Psychology, University of Bath, Bath BA2 7AY, England, UK.

Bristol Medical School, University of Bristol, Bristol BS8 1QU, England, UK.

出版信息

Brain Commun. 2025 Sep 1;7(5):fcaf279. doi: 10.1093/braincomms/fcaf279. eCollection 2025.

DOI:10.1093/braincomms/fcaf279
PMID:40901302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401560/
Abstract

As viable pharmacotherapies and blood biomarkers emerge for dementia treatment and screening, there remains a great need for accurate, sensitive biomarkers of cognitive function. We have previously demonstrated that Fastball, a new Electroencephalography (EEG) method for the passive and objective measurement of recognition memory that requires no behavioural memory response or task comprehension, is sensitive to cognitive dysfunction in Alzheimer's disease. Here we present new evidence that Fastball is sensitive to amnestic dysfunction in an earlier stage of the dementia lifecourse, Mild Cognitive Impairment (MCI). 53 MCI patients and 54 healthy older adult (HOA) controls completed a 3-min Fastball task in which they passively viewed rapidly presented images while EEG captured their automatic ability to differentiate between images based on previous exposure. They also completed neuropsychological assessments of memory (Delayed Match to Sample-48), sustained attention (Psychomotor Vigilance Task), and general cognitive function (Addenbrookes Cognitive Exam-iii). Participants were re-tested after 1 year to establish the test-retest reliability of Fastball in HOAs, and the sensitivity of Fastball to cognitive decline in MCI patients, over a 1 year period. Amnestic MCI patients showed significantly reduced Fastball responses compared with non-amnestic MCI patients ( = 0.001, Cohen's = 0.98) and HOA controls ( = 0.005, Cohen's = 0.64). Regression analyses showed that Fastball EEG responses were selectively predictive of neuropsychological measures of recognition memory and not attention. Between baseline and year one follow-up Fastball showed moderate to good test-retest reliability in HOA controls, and the six MCI-dementia converters showed a trend for lower Fastball responses at baseline which will be confirmed with further longitudinal assessment. Fastball is further validated as a viable method for testing recognition memory in cognitively impaired populations. We have demonstrated that it is selectively predictive of memory dysfunction and not attention or other cognitive functions. It is passive, non-invasive, quick to administer and uses cheap, scalable EEG technology. Fastball is a viable functional biomarker that can help to advance cognitive assessment in MCI.

摘要

随着用于痴呆症治疗和筛查的可行药物疗法及血液生物标志物的出现,对准确、灵敏的认知功能生物标志物仍有巨大需求。我们之前已经证明,Fastball是一种用于被动和客观测量识别记忆的新脑电图(EEG)方法,无需行为记忆反应或任务理解,对阿尔茨海默病中的认知功能障碍敏感。在此,我们给出新证据,表明Fastball在痴呆症病程的早期阶段——轻度认知障碍(MCI)中,对遗忘功能障碍敏感。53名MCI患者和54名健康老年人(HOA)对照完成了一项3分钟的Fastball任务,在此任务中,他们被动观看快速呈现的图像,同时EEG记录他们基于先前接触对图像进行区分的自动能力。他们还完成了记忆(延迟匹配样本 - 48)、持续注意力(精神运动警觉任务)和一般认知功能(Addenbrookes认知测试 - iii)的神经心理学评估。参与者在1年后重新接受测试,以确定Fastball在HOA中的重测信度,以及Fastball在1年期间对MCI患者认知衰退的敏感性。遗忘型MCI患者与非遗忘型MCI患者( = 0.001,科恩d = 0.98)及HOA对照( = 0.005,科恩d = 0.64)相比,Fastball反应显著降低。回归分析表明,Fastball EEG反应可选择性地预测识别记忆的神经心理学指标,而非注意力。在基线和一年随访之间,Fastball在HOA对照中显示出中度至良好的重测信度,6名从MCI转变为痴呆症的患者在基线时Fastball反应有降低趋势,这将通过进一步的纵向评估得到证实。Fastball作为一种用于测试认知受损人群识别记忆的可行方法得到了进一步验证。我们已经证明,它可选择性地预测记忆功能障碍,而非注意力或其他认知功能。它是被动、非侵入性的,实施快速,并且使用廉价、可扩展的EEG技术。Fastball是一种可行的功能生物标志物,可有助于推进MCI中的认知评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/4daeca38e340/fcaf279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/76507da1cc17/fcaf279_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/253b15c1fba3/fcaf279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/ebce26775ebf/fcaf279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/d5b1649ec346/fcaf279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/4daeca38e340/fcaf279f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/76507da1cc17/fcaf279_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/253b15c1fba3/fcaf279f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/ebce26775ebf/fcaf279f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/d5b1649ec346/fcaf279f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4835/12401560/4daeca38e340/fcaf279f4.jpg

相似文献

1
A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment.使用快球记忆评估对轻度认知障碍中的识别记忆进行被动和客观测量。
Brain Commun. 2025 Sep 1;7(5):fcaf279. doi: 10.1093/braincomms/fcaf279. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.
5
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
8
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
9
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
10
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.

本文引用的文献

1
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.作为一种临床生物学概念的阿尔茨海默病——国际工作组建议
JAMA Neurol. 2024 Dec 1;81(12):1304-1311. doi: 10.1001/jamaneurol.2024.3770.
2
P-tau217 and other blood biomarkers of dementia: variation with time of day.P-tau217 和其他痴呆症血液生物标志物:随时间的变化。
Transl Psychiatry. 2024 Sep 13;14(1):373. doi: 10.1038/s41398-024-03084-7.
3
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
4
Alzheimer disease blood biomarkers: considerations for population-level use.阿尔茨海默病血液生物标志物:在人群水平应用的考虑因素。
Nat Rev Neurol. 2024 Aug;20(8):495-504. doi: 10.1038/s41582-024-00989-1. Epub 2024 Jun 11.
5
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
6
Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape.用于阿尔茨海默病的基于血液的生物标志物:在变革的全球医疗保健环境中的当前状态和未来用途。
Neuron. 2023 Sep 20;111(18):2781-2799. doi: 10.1016/j.neuron.2023.05.017. Epub 2023 Jun 8.
7
Global estimates on the number of persons across the Alzheimer's disease continuum.全球范围内阿尔茨海默病患者人数的估计。
Alzheimers Dement. 2023 Feb;19(2):658-670. doi: 10.1002/alz.12694. Epub 2022 Jun 2.
8
Familiarity Deficits for Words and Objects in Amnestic Mild Cognitive Impairment in a Context Minimizing the Role of Recollection.情景最小化再认作用下遗忘型轻度认知损害患者的单词和物体熟悉性缺陷
J Gerontol B Psychol Sci Soc Sci. 2022 Dec 29;77(12):2232-2240. doi: 10.1093/geronb/gbac073.
9
Alzheimer's Disease: Epidemiology and Clinical Progression.阿尔茨海默病:流行病学与临床进展
Neurol Ther. 2022 Jun;11(2):553-569. doi: 10.1007/s40120-022-00338-8. Epub 2022 Mar 14.
10
A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.使用快球记忆评估法评估阿尔茨海默病的被动客观识别记忆。
Brain. 2021 Oct 22;144(9):2812-2825. doi: 10.1093/brain/awab154.